Interactions of SARS-CoV-2 Infection and Genetic Variation on the Risk of Cognitive Decline and Alzheimer’s Disease in Ancestral and Admixed Populations (ISAVRAD)

  • Funding provided by the National Institute on Aging under Grant No. 1U19AG076581-01A1, and the Alzheimer's Assocation. UT Health San Antonio IRB Number: 20210013HU.

How the Research Happens

The ISAVRAD Consortium explores how genetics affect brain health, focusing on diverse communities worldwide. The research is carried out by 5 Cores and 4 Projects.

Learn More Leadership

5 Cores

  • Administrative Core
  • Clinical Core
  • Neuroimaging Core
  • Biomarker Core
  • Data Management/Statistics Core
Learn More about Cores

4 Projects

  • Longitudinal Epidemiology of Cognitive Decline and Alzheimer’s Dementia after SARS-CoV-2 Infection
  • Gene-Environment Interactions in Cognitive Decline and ADRD
  • Neuroimaging Markers of COVID-19 and ADRD Progression
  • Pathophysiological Insights and Prevention Strategies
Learn More about Projects

Our Research Projects

Each ISAVRAD Project brings forth unique information about Brain Health.

Project 1: Longitudinal Epidemiology

Project 2: Gene x Environment Interactions

Project 3: Neuroimaging and Outcomes

Project 4: Behavioral Health Impacts

Where are Data Collected?

San Antonio and Laredo, Texas

Focus on recruiting individuals of Hispanic Mexican-American ancestry.

Bronx County, New York

Focus on recruiting 50% Hispanic Latinos (of Puerto Rican or Dominican Republic descent) and 50% African-Americans from the U.S. and the Caribbean.

King County, Washington State

Focus on recruiting ethnically Native-American participants.

Ibadan, Nigeria

Focus on recruiting Black Africans.

Jujuy, Argentina

Focus on recruiting Amerindians from the Central Andes mountains in the Province of Jujuy.

Who can enroll?

1

Meet Age, Location Requirement

Over age 60, belonging to one of the studied ethnic groups at each site

2

Confirmed PCR

Confirmed PCR evaluation for SARS-Cov-2 (either positive or negative) within first 2 years of pandemic.

3

Or No History of COVID

If PCR was negative, having no history of COVID-19 symptoms in the first 2 years at their place of residence.

Leading the Charge

Discover the experts leading research on genetics and cognitive decline, with decades of global experience in diverse populations.

Dr. Gabriel de Erausquin

Dr. Gabriel de Erausquin

UT Health San Antonio

Dr. Sudha Seshadri

Dr. Sudha Seshadri

UT Health San Antonio

Ms. Mindy Katz

Ms. Mindy Katz

Albert Einstein College of Medicine

Dr. Tom Patterson

Dr. Tom Patterson

UT Health San Antonio

Dr. Gabriela Gonzalez Aleman

Dr. Gabriela Gonzalez Aleman

Universidad Católica Argentina

THANK YOU TO OUR FUNDERS AND PARTNERS

Contact us

Get Consortium Updates!

Learn about Data Releases

Get updates on study results

Fill up the form or send an email to get in touch with our study team.

We don’t share or sell your email address publicly

Ready to Work with ISAVRAD Data?

ISAVRAD Data

Working with ISAVRAD data is simple! Follow these steps and you'll be working with ISAVRAD data shortly!

1) Submit a Data Proposal

Articulate your aims, dissemination goals, and analysis plan.

2) Await Decision, Data

The ISAVRAD Team will meet to review your proposal. Once reviewed, you'll receive a decision, feedback, and if approved, data.

The ISAVRAD Consortium explores how genetics affect brain health, focusing on diverse communities worldwide.

Funding provided by the National Institute on Aging under Grant No. 1U19AG076581-01A1, and the Alzheimer's Assocation. UT Health San Antonio IRB Number: 20210013HU.

Copyright © 2025 ISAVRAD Consortium. All Rights Reserved